e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Roles of HIF1 and HIF2 in pulmonary hypertension: it all depends on the context
Gregory B. Waypa, Paul T. Schumacker
Source:
Eur Respir J, 54 (6) 1901929; 10.1183/13993003.01929-2019
Journal Issue:
December
Disease area:
Airway diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Gregory B. Waypa, Paul T. Schumacker. Roles of HIF1 and HIF2 in pulmonary hypertension: it all depends on the context. Eur Respir J, 54 (6) 1901929; 10.1183/13993003.01929-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension
Source: Eur Respir J, 54 (6) 1900378; 10.1183/13993003.00378-2019
Year: 2019
RASSF1A regulates ROS-HIF axis in hypoxia driven pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: novel insights
Year: 2016
Hypoxia-induced miR-130a is a novel repressor of BMPR2 gene expression in experimental pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms
Year: 2012
Altered expression of the Smad signalling pathway: implications for COPD pathogenesis
Source: Eur Respir J 2006; 28: 533-541
Year: 2006
Functional upregulation of PRMT2 in chronic hypoxia-induced pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 721s
Year: 2004
Selective inhibition of BET bromodomain and their effect on nuclear factor-kappa B activation in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Inhibition of the miRNA familiy miR-130 restores the expression of CDKN1A (p21) and ameliorates hypoxia-induced pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Stabilised ferroportin activity affects pulmonary vascular cells responses: implications for pulmonary hypertension
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018
A novel piperidine attenuates pulmonary arterial hypertension via regulating BMP2 and PTGS2 levels
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018
The matrix-fibroblast interplay contributes to HIF-1 alpha pathway activation: a possible therapeutic target in idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro
Year: 2020
Dual mechanism of platelet-derived growth factor (PDGF)-receptor: Contribution of vascular response to the pathogenesis of pulmonary hypertension (PH)
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Role and regulation of Jumonji C domain-containing histone demethylases 1A and 2B in pulmonary hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
AntagomiR directed against miR-20a restores BMP signaling in hypoxia-induced pulmonary hypertension in vivo
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
Selective TSC1 deletion in smooth muscle activates mTOR signaling and induces pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015
Pharmacological activation of Nur77 enhances BMP signalling and inhibits vascular remodelling in pulmonary arterial hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018
The modulatory effects of Nrf2 activators in a pulmonary arterial hypertension model
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020
The hypoxia-induced miR-130 increases proliferation of pulmonary arterial smooth muscle cells by targeting the tumour suppressor CDKN1A (p21)
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Role of Gremlin in pulmonary hypertension
Source: Annual Congress 2012 - Contributing factors to pulmonary hypertension
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept